| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide… |
Enrollment closed, study ongoing |
| 2026-08-13 | NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide… |
Trial sites reduced: 241 -> 234 locations |
| 2026-08-12 | NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. |
Enrollment closed, study ongoing |
| 2026-08-12 | NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. |
Sponsor changed: Evopoint Biosciences Inc. -> Astellas Pharma Global Development, Inc. |
| 2026-08-12 | NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. |
date change Primary completion pushed: 2025-06-30 -> 2026-12-30 |
| 2026-08-12 | NCT06792435 XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. |
date change Completion pushed: 2025-12-31 -> 2027-06-30 |
| 2026-08-07 | NCT07475806 A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With… |
Trial sites expanded: 12 -> 21 locations |
| 2026-08-01 | NCT06901531 A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… |
date change Primary completion moved earlier: 2028-09-30 -> 2027-03-31 |
| 2026-08-01 | NCT06901531 A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… |
date change Completion moved earlier: 2028-09-30 -> 2027-03-31 |
| 2026-07-28 | NCT07409272 A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either… |
Trial sites expanded: 34 -> 48 locations |
| 2026-07-24 | NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors |
Enrollment increased: 210 -> 798 participants |
| 2026-07-24 | NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors |
Trial arms changed: 4 -> 18 |
| 2026-07-24 | NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors |
date change Primary completion pushed: 2028-04-30 -> 2030-04-30 |
| 2026-07-24 | NCT05719558 A Study of ASP1002 in Adults for Treatment of Solid Tumors |
date change Completion pushed: 2028-05-31 -> 2030-05-31 |
| 2026-07-24 | NCT07673887 A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-28 | NCT07730021 A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid… | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06862219 | A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer | Metastatic Urothelial Carcinoma | Recruiting |
| Phase 3 | |||
| NCT05970172 | A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney… | Chronic Kidney Disease | Recruiting |
| NCT07673887 | A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric… | Gastric Adenocarcinoma | Recruiting |
| NCT07409272 | A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either… | Pancreatic Cancer | Recruiting |
| NCT06901531 | A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Recruiting |
| NCT07566156 | Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy… | Urothelial Cancer | Recruiting |
| NCT07566052 | A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell… | Non-small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT03504397 | A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy… | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Active, Not Recruiting |
| NCT04223856 | Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced… | Urothelial Cancer | Active, Not Recruiting |
| NCT05621616 | A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in… | Neurogenic Detrusor Overactivity | Active, Not Recruiting |
| NCT06440967 | A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer… | Hot Flashes | Active, Not Recruiting |
| NCT03653507 | A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as… | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07005154 | A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer | Prostate Cancer | Recruiting |
| NCT07475806 | A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With… | Muscle-invasive Bladder Cancer | Recruiting |
| NCT04225117 | A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic… | Locally Advanced or Metastatic Malignant Solid Tumors | Active, Not Recruiting |
| NCT03505320 | A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer | Pharmacokinetics of Zolbetuximab | Active, Not Recruiting |
| NCT03816163 | A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer | Pancreatic Cancer | Active, Not Recruiting |
| NCT02960022 | A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide… | Prostate Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07287995 | A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid… | Locally Advanced or Metastatic Malignant Solid Tumors | Recruiting |
| NCT07488676 | A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other… | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma | Recruiting |
| NCT05520567 | A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People… | Acute Myeloid Leukemia (AML) | Active, Not Recruiting |
| NCT07730021 | A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid… | Locally Advanced or Metastatic Solid Tumors | Not Yet Recruiting |
| NCT06792435 | XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. | Pancreatic Adenocarcinoma Metastatic | Active, Not Recruiting |
| Phase 1 | |||
| NCT04729114 | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer | Prostate Cancer | Recruiting |
| NCT07339267 | A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With… | Prostate Cancer | Recruiting |